Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas Kühne

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)|March 15, 2019
[Edema - the nephrologist's perspective]Lucas Kühne, Paul Thomas Brinkkötter
Deutsche Medizinische Wochenschrift (1946)|November 6, 2024
[100 years thrombotic thrombocytopenic purpura (TTP) - lessons learned?]Ralph Wendt, Linus Völker, Martin Bommer, et al.
BMC Nephrology|June 19, 2024
Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS- real-world dataKristina Schönfelder, Lucas Kühne, Lena Schulte-Kemna, et al.
Scientific Reports|April 28, 2023
Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGSThomas Osterholt, Polina Todorova, Lucas Kühne, et al.
Kidney International|December 7, 2020
A fast and simple clearing and swelling protocol for 3D in-situ imaging of the kidney across scalesDavid Unnersjö-Jess, Linus Butt, Martin Höhne, et al.
Kidney International Reports|July 31, 2024
Challenges and Considerations in Managing Thrombotic Microangiopathy and Disseminated Intravascular Coagulation in Postpartum HemorrhageJessica K Kaufeld, Ulf Schönermarck, Lucas Kühne, et al.
Kidney International Reports|October 21, 2024
Erratum to "Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition" [<i>Kidney International Reports</i> Volume 9, Issue 4, April 2024, Pages 919-928]Jessica K Kaufeld, Lucas Kühne, Ulf Schönermarck, et al.
British Journal of Haematology|September 29, 2021
First use of the anti-VWF nanobody caplacizumab to treat iTTP in pregnancyLucas Kühne, Linus A Völker, Henning Hagmann, et al.
Kidney International Reports|May 20, 2024
Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement InhibitionJessica K Kaufeld, Lucas Kühne, Ulf Schönermarck, et al.
Journal of Thrombosis and Haemostasis : JTH|January 9, 2022
Alternate-day dosing of caplacizumab for immune-mediated thrombotic thrombocytopenic purpuraLucas Kühne, Jessica Kaufeld, Linus A Völker, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|March 15, 2019
[Edema - the nephrologist's perspective]Lucas Kühne, Paul Thomas Brinkkötter
Deutsche Medizinische Wochenschrift (1946)|November 6, 2024
[100 years thrombotic thrombocytopenic purpura (TTP) - lessons learned?]Ralph Wendt, Linus Völker, Martin Bommer, et al.
BMC Nephrology|June 19, 2024
Clinical efficacy and safety of switching from eculizumab to ravulizumab in adult patients with aHUS- real-world dataKristina Schönfelder, Lucas Kühne, Lena Schulte-Kemna, et al.
Scientific Reports|April 28, 2023
Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGSThomas Osterholt, Polina Todorova, Lucas Kühne, et al.
Kidney International|December 7, 2020
A fast and simple clearing and swelling protocol for 3D in-situ imaging of the kidney across scalesDavid Unnersjö-Jess, Linus Butt, Martin Höhne, et al.
Kidney International Reports|July 31, 2024
Challenges and Considerations in Managing Thrombotic Microangiopathy and Disseminated Intravascular Coagulation in Postpartum HemorrhageJessica K Kaufeld, Ulf Schönermarck, Lucas Kühne, et al.
Kidney International Reports|October 21, 2024
Erratum to "Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition" [<i>Kidney International Reports</i> Volume 9, Issue 4, April 2024, Pages 919-928]Jessica K Kaufeld, Lucas Kühne, Ulf Schönermarck, et al.
British Journal of Haematology|September 29, 2021
First use of the anti-VWF nanobody caplacizumab to treat iTTP in pregnancyLucas Kühne, Linus A Völker, Henning Hagmann, et al.
Kidney International Reports|May 20, 2024
Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement InhibitionJessica K Kaufeld, Lucas Kühne, Ulf Schönermarck, et al.
Journal of Thrombosis and Haemostasis : JTH|January 9, 2022
Alternate-day dosing of caplacizumab for immune-mediated thrombotic thrombocytopenic purpuraLucas Kühne, Jessica Kaufeld, Linus A Völker, et al.
Pageof 2